Created in 1964, Inserm is a public institution with a scientific and technological vocation under the dual supervision of the Ministry of Health and the Ministry of Higher Education and Research. Dedicated to research in the fields of biology, medicine and public health, the institute is active in all aspects from the laboratory to the hospital bed. It is composed of 281 research units, 2 Inserm units overseas, more than 5 000 researchers, engineers and technicians.
Actually, Inserm is in 1st position in Europe among the academic and research institutions in the field of biomedical with almost 12 000 publications a year and 2nd world position after the National Institutes of Health (NIH). The institute is the 1st European depositor of patents in the pharmaceutical and biomedical sectors.
The Centre de physiopathologie de Toulouse-Purpan (CPTP), created in 2002 is a research institute offering a productive and organized scientific environment focusing on 3 themes: immunology, inflammation and infectious diseases. It is composed of 11 research teams with international reputation, 4 cutting-edge core facilities and an efficient support team (197 total members).
The research theme spans from basic research such as the development of the immune system and its functions to translational research. The CPTP is also engaged in optimizing vaccine strategies and developing novel immunotherapies.
TEAM LEADER :
Pr. Roland Liblau is a Neurologist, Professor of Clinical Immunology, director of the Pathophysiology Research Center (UMR1043-CNRS 5282) Toulouse. He is heading an internationally renowned research laboratory. Research is focusing on the etiology and effector mechanisms underlying CNS autoimmune diseases and is based on clinical research projects as well as the generation and study of original animal models. He has published 193 articles and reviews referenced in PubMed (H factor: 54). The HCERES evaluation of his Laboratory in 2019 was outstanding for productivity and excellent for societal impact.